CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 161 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57 | -34.5% | 4,200 | -25.0% | 0.01% | -50.0% |
| Q2 2023 | $87 | +112.2% | 5,600 | +93.1% | 0.01% | +140.0% |
| Q1 2023 | $41 | +2.5% | 2,900 | -71.7% | 0.01% | +66.7% |
| Q4 2022 | $40 | -99.9% | 10,233 | -0.9% | 0.00% | -25.0% |
| Q3 2022 | $45,000 | -81.9% | 10,323 | -75.4% | 0.00% | -77.8% |
| Q2 2022 | $248,000 | +74.6% | 42,000 | +371.9% | 0.02% | +125.0% |
| Q1 2022 | $142,000 | -54.0% | 8,900 | -44.7% | 0.01% | -38.5% |
| Q4 2021 | $309,000 | -50.6% | 16,100 | -56.5% | 0.01% | -53.6% |
| Q3 2021 | $626,000 | +198.1% | 37,000 | +487.3% | 0.03% | +180.0% |
| Q2 2021 | $210,000 | – | 6,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,132,259 | $30,526,000 | 7.80% |
| Ghost Tree Capital, LLC | 400,000 | $10,784,000 | 5.62% |
| Octagon Capital Advisors LP | 761,398 | $20,527,000 | 5.48% |
| VR Adviser, LLC | 865,116 | $23,324,000 | 4.59% |
| ACUTA CAPITAL PARTNERS, LLC | 267,195 | $7,204,000 | 4.01% |
| COMMODORE CAPITAL LP | 538,812 | $14,526,000 | 3.07% |
| Ikarian Capital, LLC | 616,700 | $16,628,000 | 3.03% |
| TSP Capital Management Group, LLC | 266,545 | $7,186,000 | 2.83% |
| Ikarian Capital, LLC | 537,958 | $14,504,000 | 2.64% |
| Ikarian Capital, LLC | 506,500 | $13,656,000 | 2.49% |